| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 07/15/2004 | US20040137447 Human sphingosine-1-phosphate phosphatase |
| 07/15/2004 | US20040137446 Fab I and inhibition of apicomplexan parasites |
| 07/15/2004 | US20040137434 Novel nucleic acids and polypeptides |
| 07/15/2004 | US20040137425 Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays |
| 07/15/2004 | US20040137092 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 07/15/2004 | US20040137091 Unhydrolyzed and hydrolyzed jojoba protein having high simmondsin concentration of about 11-18% by weight simmondsin 2-(cyanomethylene)-3-hydroxy-4,5-dimethoxy-cyclohexyl-glucoside); cosmetics;detergents; films; sanitizers shampoos |
| 07/15/2004 | US20040136976 screening for agents which decrease extracellular matrix degradation; |
| 07/15/2004 | DE10260930A1 Neue Cholinoxidasen New choline |
| 07/15/2004 | CA2511656A1 Coenzyme-binding glucose dehydrogenase |
| 07/15/2004 | CA2511652A1 Enzymes and polynucleotides encoding the same |
| 07/15/2004 | CA2511553A1 Process for producing dipeptides |
| 07/15/2004 | CA2511227A1 Dna polymerase blends and uses thereof |
| 07/15/2004 | CA2511025A1 Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content |
| 07/15/2004 | CA2510561A1 Malate dehydrogenase as a target for herbicides |
| 07/15/2004 | CA2508948A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 07/15/2004 | CA2508592A1 High pressure spray-dry of bioactive materials |
| 07/14/2004 | EP1437414A2 A method for promoting biocatalyst diversity |
| 07/14/2004 | EP1437412A1 Genes participating in the synthesis of fatty acid having trans-11-,cis-13- condjugated double bond and utilization thereof |
| 07/14/2004 | EP1437411A1 Glucose dehydrogenase |
| 07/14/2004 | EP1437410A1 Novel selenocystein-containing proteins |
| 07/14/2004 | EP1437401A1 Oxidoreductase |
| 07/14/2004 | EP1437399A1 Yeast extract solution, its preparation and use for cell-free protein synthesis |
| 07/14/2004 | EP1437366A1 MHC antigen complexes for detecting and purifying antigen-specific T cells |
| 07/14/2004 | EP1436402A2 Coffee plant with reduced alpha-d-galactosidase activity |
| 07/14/2004 | EP1436398A2 Glucosyltransferases which glucosylate abscisic acid |
| 07/14/2004 | EP1436390A2 Retinoid inducible proteins of vascular smooth muscle cells and uses thereof |
| 07/14/2004 | EP1436389A2 Thrombin-cleavable chimeric proteins |
| 07/14/2004 | EP1436388A2 Novel human proteases and polynucleotides encoding the same |
| 07/14/2004 | EP1436387A2 Enzymatic conversion of blood group a, b, and ab red blood cells using alpha-n-acetylgalactosaminidases and alpha-galactosidases with unique substrate specificities and kinetic properties |
| 07/14/2004 | EP1436386A2 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli |
| 07/14/2004 | EP1436385A2 Dna polymerases and mutants thereof |
| 07/14/2004 | EP1436384A2 Mutated abl kinase domains |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436382A2 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 07/14/2004 | EP1436316A2 Subcellular targeting of therapeutic proteins |
| 07/14/2004 | EP1436309A2 Bgl3 beta-glucosidase and nucleic acids encoding the same |
| 07/14/2004 | EP1436058A1 Separation medium, its preparation and its use |
| 07/14/2004 | EP1436056A2 Macroporous gel, its preparation and its use |
| 07/14/2004 | EP1435989A1 Ptp1b inhibitors and ligands |
| 07/14/2004 | EP1435957A2 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 07/14/2004 | EP1220943B1 Cellular test system for investgation of metabolic activity of active forms of cytochrome P450 2D6 |
| 07/14/2004 | EP1183265A4 Novel fabh enzyme, compositions capable of binding to said enzyme and methods of use thereof |
| 07/14/2004 | EP1114021B1 NEW SALTS OF HMG-CoA REDUCTASE INHIBITORS |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP1009427A4 USE OF FACTOR XIIIa INHIBITORS TO TREAT ATHEROSCLEROSIS |
| 07/14/2004 | EP0912725B1 Glycosidase enzymes |
| 07/14/2004 | EP0901468B1 Preparation of lactams from aliphatic alpha,omega-dinitriles |
| 07/14/2004 | EP0837943B1 In vivo assays for modulators of sterol biosynthesis |
| 07/14/2004 | EP0827534B1 Detergents comprising cellulases |
| 07/14/2004 | EP0732398B1 Novel tyrosine kinase |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | EP0538461B1 Transgenic plants with altered polyol content |
| 07/14/2004 | CN1513116A Recovery of enzyme activity from enveloped viruses |
| 07/14/2004 | CN1513059A Enzymes having alpha amylase activity and method of use thereof |
| 07/14/2004 | CN1513056A Production of bioarailable folic acid |
| 07/14/2004 | CN1512998A Proteins producing altered immunogenic response and methods of making and using the same |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1511952A Recombined glucokinase |
| 07/14/2004 | CN1157475C Bacterial strain producing phloem fibre degummin enzyme and its application in ramie and hemp degumming |
| 07/14/2004 | CN1157175C Personal care compositions containing active proteins tethered to water insoluble substrate |
| 07/13/2004 | US6762346 Transgenic plants and plant cells, in which an amylopectin with an altered degree of branching is synthesized |
| 07/13/2004 | US6762345 For oils rich in keto fatty acids which are useful for industrial applications such as drying agents and monomer precursors |
| 07/13/2004 | US6762344 For herbicide resistance, male sterility |
| 07/13/2004 | US6762343 Mice with combined disruption of Gpx1 and Gpx2 genes have growth retardation, hypothermia, and colitis and provide a mouse model for cancer |
| 07/13/2004 | US6762342 Expression vector for use in generating animal model to evaluate genetic disorders sensitivity to pain and tension |
| 07/13/2004 | US6762286 Modified vitamin K-dependent polypeptides |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762052 The enzymes are useful in metabolism studies, in screening of compounds for biological or pharmacological activity, as well as serving as a bio-indicator of disease states or susceptibility to disease states |
| 07/13/2004 | US6762051 Methods of inhibiting helicobacter pylori |
| 07/13/2004 | US6762046 Polypeptide having β-fructofuranosidase activity |
| 07/13/2004 | US6762045 Membrane derived caspase-3, compositions comprising the same and methods of use therefor |
| 07/13/2004 | US6762044 Disintegrins; metalloproteases; drug delivery; antithrombotic, antimetastatic agents |
| 07/13/2004 | US6762043 High throughput screening systems for identifying compounds useful in the treatment of cellular proliferation disorders; can be performed in plurality simultaneously with fluorescence of absorbance readouts |
| 07/13/2004 | US6762042 DNA molecules encoding human NHL a DNA helicase |
| 07/13/2004 | US6762039 Identification of novel cysteine proteases in gram-positive microorganisms by providing the nucleic acid and amino acid sequences for the bacillus subtilis cysteine proteases cp1, cp2 and cp3 |
| 07/13/2004 | US6762037 Process for producing coenzyme Q10 |
| 07/13/2004 | CA2414487A1 Methods and genetic sequences for producing male sterile plants, and plants genetically modified to alter anther development |
| 07/13/2004 | CA2137748C Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants |
| 07/13/2004 | CA2123908C Novel dna clones and uses thereof |
| 07/08/2004 | WO2004057016A2 METHODS OF CAPTURING, DETECTING AND QUANTIFYING RNA:DNA HYBRIDS AND A MODIFIED RNase H USEFUL THEREIN |
| 07/08/2004 | WO2004057003A2 Method for producing aminoacids |
| 07/08/2004 | WO2004057002A2 Production of heterologous glycosylated proteins in bryophyte cells |
| 07/08/2004 | WO2004057001A2 Method for the production of polyunsaturated fatty acids |
| 07/08/2004 | WO2004057000A2 Methods and compositions for modulating tuber formation in tuber-producing plants |
| 07/08/2004 | WO2004056999A1 Plant cells and plants which synthesize a starch with an increased final viscosity |
| 07/08/2004 | WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | WO2004056992A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same |
| 07/08/2004 | WO2004056991A2 Novel angiogenic molecular target and uses thereof |
| 07/08/2004 | WO2004056990A1 Novel nitrile hydratase |
| 07/08/2004 | WO2004056989A2 Human variants of kallikrein-2 and kallikrein-3 and uses thereof |
| 07/08/2004 | WO2004056988A2 Galactanase variants |
| 07/08/2004 | WO2004056985A2 Production of crude krill enzyme solution, the crude enzyme solution and freeze-dried product thereof and feeds using the same |
| 07/08/2004 | WO2004056983A2 Metalloprotease proteins |
| 07/08/2004 | WO2004056982A2 Kinase sequences |
| 07/08/2004 | WO2004056981A2 Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same |
| 07/08/2004 | WO2004056980A1 Activating protease of oil grains and hydrolyzing vegetable proteins |
| 07/08/2004 | WO2004056968A2 Generation of plants with altered oil content |
| 07/08/2004 | WO2004056967A2 Generation of plants with altered oil content |